{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:45:58Z","timestamp":1792809958553,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40262-023-01334-3","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:05:08Z","timestamp":1704222308000},"page":"211-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-7057","authenticated-orcid":false,"given":"Audrick","family":"Gibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lanoisel\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gouin-Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Pontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Azarnoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andranik","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Molliex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gergel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"4","key":"1334_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2165\/00003495-199040040-00003","volume":"40","author":"M Verstraete","year":"1990","unstructured":"Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs. 1990;40(4):498\u2013530. https:\/\/doi.org\/10.2165\/00003495-199040040-00003.","journal-title":"Drugs"},{"issue":"4 Suppl.","key":"1334_CR2","doi-asserted-by":"publisher","first-page":"258S","DOI":"10.1378\/chest.108.4_supplement.258s","volume":"108","author":"J Hirsh","year":"1995","unstructured":"Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108(4 Suppl.):258S-S275. https:\/\/doi.org\/10.1378\/chest.108.4_supplement.258s.","journal-title":"Chest"},{"issue":"12","key":"1334_CR3","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/jth.13555","volume":"14","author":"HC Hemker","year":"2016","unstructured":"Hemker HC. A century of heparin: past, present and future. J Thromb Haemost. 2016;14(12):2329\u201338. https:\/\/doi.org\/10.1111\/jth.13555. (Epub 2016 Dec 16).","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1334_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/bj2620225","volume":"262","author":"B Bray","year":"1989","unstructured":"Bray B, Lane DA, Freyssinet JM, Pejler G, Lindahl U. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Biochem J. 1989;262(1):225\u201332. https:\/\/doi.org\/10.1042\/bj2620225.","journal-title":"Biochem J"},{"issue":"5","key":"1334_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1538-7836.2007.02477.x.Erratum.In:JThrombHaemost.2007Jun;5(6):1343","volume":"5","author":"GT Gerotziafas","year":"2007","unstructured":"Gerotziafas GT, Petropoulou AD, Verdy E, Samama MM, Elalamy I. Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation. J Thromb Haemost. 2007;5(5):955\u201362. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02477.x.Erratum.In:JThrombHaemost.2007Jun;5(6):1343.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1334_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1051\/ject\/200537265","volume":"37","author":"D Machin","year":"2005","unstructured":"Machin D, Devine P. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement. J Extra Corpor Technol. 2005;37(3):265\u201371.","journal-title":"J Extra Corpor Technol"},{"issue":"2","key":"1334_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jcla.21823","volume":"30","author":"X Hong","year":"2016","unstructured":"Hong X, Shan PR, Huang WJ, Zhu QL, Xiao FY, et al. Influence of body mass index on the activated clotting time under weight-based heparin dose. J Clin Lab Anal. 2016;30(2):108\u201313. https:\/\/doi.org\/10.1002\/jcla.21823. (Epub 2014 Nov 25).","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"1334_CR8","first-page":"809","volume":"46","author":"M Inoue","year":"1997","unstructured":"Inoue M, Hirose Y, Gamou M, Goto M. Effect of hemodilution with dextran and albumin on activated clotting time (ACT). Masui. 1997;46(6):809\u201312 (Japanese).","journal-title":"Masui"},{"issue":"7","key":"1334_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14740338.2016.1177020","volume":"15","author":"K Azarnoush","year":"2016","unstructured":"Azarnoush K, Pereira B, Lebreton A, Zenut MC, Chenaf C, Vedat E, et al. Are all heparins safe for on-pump heart surgery? Expert Opin Drug Saf. 2016;15(7):897\u2013901. https:\/\/doi.org\/10.1080\/14740338.2016.1177020. (Epub 2016 May 3).","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1334_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1051\/ject\/199830273","volume":"30","author":"L Dyck","year":"1998","unstructured":"Dyck L, Friesen RM. Do different heparin brands influence activated clotting times? J Extra Corpor Technol. 1998;30(2):73\u20136.","journal-title":"J Extra Corpor Technol"},{"issue":"5","key":"1334_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1445-2197.1995.tb00648.x","volume":"65","author":"P Subramaniam","year":"1995","unstructured":"Subramaniam P, Skillington P, Tatoulis J. Heparin-rebound in the early postoperative phase following cardiopulmonary bypass. Aust N Z J Surg. 1995;65(5):331\u20133. https:\/\/doi.org\/10.1111\/j.1445-2197.1995.tb00648.x.","journal-title":"Aust N Z J Surg"},{"issue":"5","key":"1334_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/bja\/aex044","volume":"118","author":"X Delavenne","year":"2017","unstructured":"Delavenne X, Ollier E, Chollet S, Sandri F, Lanoisel\u00e9e J, Hodin S, et al. Pharmacokinetic\/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass. Br J Anaesth. 2017;118(5):705\u201312. https:\/\/doi.org\/10.1093\/bja\/aex044.","journal-title":"Br J Anaesth"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-015-0404-5","volume":"13","author":"Z Jia","year":"2015","unstructured":"Jia Z, Tian G, Ren Y, Sun Z, Lu W, Hou X. Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery. J Transl Med. 2015;13:45. https:\/\/doi.org\/10.1186\/s12967-015-0404-5.","journal-title":"J Transl Med"},{"issue":"4","key":"1334_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/psp4.12612","volume":"10","author":"G Ayral","year":"2021","unstructured":"Ayral G, Si Abdallah JF, Magnard C, Chauvin J. A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: the COSSAC approach. CPT Pharmacometr Syst Pharmacol. 2021;10(4):318\u201329. https:\/\/doi.org\/10.1002\/psp4.12612.","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"2","key":"1334_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/psp4.12742","volume":"11","author":"M Prague","year":"2022","unstructured":"Prague M, Lavielle M. SAMBA: A novel method for fast automatic model building in nonlinear mixed-effects models. CPT Pharmacometr Syst Pharmacol. 2022;11(2):161\u201372. https:\/\/doi.org\/10.1002\/psp4.12742. (Epub 2022 Feb 1).","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"1","key":"1334_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341. https:\/\/doi.org\/10.1159\/000180580.","journal-title":"Nephron"},{"key":"1334_CR17","unstructured":"Monolix 2019 User guide. Version 2021. http:\/\/monolix.lixoft.com\/single-page\/. Accessed 21 Dec 2023."},{"issue":"10","key":"1334_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.56","volume":"2","author":"K Ito","year":"2013","unstructured":"Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacometr Syst Pharmacol. 2013;2(10): e79. https:\/\/doi.org\/10.1038\/psp.2013.56.","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"key":"1334_CR19","unstructured":"R: the R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 25 Jan 2023."},{"key":"1334_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106553","volume":"214","author":"R Chaux","year":"2022","unstructured":"Chaux R, Lanoisel\u00e9e J, Magand C, Zufferey P, Delavenne X, Ollier E. Robust K-PD model for activated clotting time prediction and UFH dose individualisation during cardiopulmonary bypass. Comput Methods Programs Biomed. 2022;214: 106553. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106553. (Epub 2021 Nov 27).","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"1334_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/bcp.12930","volume":"82","author":"H Al-Sallami","year":"2016","unstructured":"Al-Sallami H, Newall F, Monagle P, Ignjatovic V, Cranswick N, Duffull S. Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. Br J Clin Pharmacol. 2016;82(1):178\u201384.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1334_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jcph.2007","volume":"62","author":"AM Salem","year":"2022","unstructured":"Salem AM, Niu T, Li C, Moffett BS, Ivaturi V, Gopalakrishnan M. Reassessing the pediatric dosing recommendations for unfractionated heparin using real-world data: a pharmacokinetic-pharmacodynamic modeling approach. J Clin Pharmacol. 2022;62(6):733\u201346.","journal-title":"J Clin Pharmacol"},{"issue":"6S","key":"1334_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.pcc.0000537571.01928.c4","volume":"19","author":"M Grimaud","year":"2018","unstructured":"Grimaud M, Urien S, Borgel D, et al. Abstract P-114: pharmacokinetic analysis of unfractionated heparin in critically ill children during extracorporeal membrane oxygenation: do we achieve the target? Pediatr Crit Care Med. 2018;19(6S):83\u20134.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"1334_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/abbi.1993.1251","volume":"303","author":"H Mohri","year":"1993","unstructured":"Mohri H, Ohkubo T. Fibrinogen binds to heparin: the relationship of the binding of other adhesive proteins to heparin. Arch Biochem Biophys. 1993;303(1):27\u201331. https:\/\/doi.org\/10.1006\/abbi.1993.1251.","journal-title":"Arch Biochem Biophys"},{"issue":"25","key":"1334_CR25","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1021\/bi0344073","volume":"42","author":"S Yakovlev","year":"2003","unstructured":"Yakovlev S, Gorlatov S, Ingham K, Medved L. Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site. Biochemistry. 2003;42(25):7709\u201316. https:\/\/doi.org\/10.1021\/bi0344073.","journal-title":"Biochemistry"},{"issue":"4\u20135","key":"1334_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.thromres.2003.09.014","volume":"111","author":"C Mouton","year":"2003","unstructured":"Mouton C, Calderon J, Janvier G, Vergnes MC. Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine. Thromb Res. 2003;111(4\u20135):273\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2003.09.014.","journal-title":"Thromb Res"},{"issue":"22","key":"1334_CR27","doi-asserted-by":"publisher","first-page":"19892","DOI":"10.1074\/jbc.M111.228114","volume":"286","author":"A Ori","year":"2011","unstructured":"Ori A, Wilkinson MC, Fernig DG. A systems biology approach for the investigation of the heparin\/heparan sulfate interactome. J Biol Chem. 2011;286(22):19892\u2013904. https:\/\/doi.org\/10.1074\/jbc.M111.228114. (Epub 2011 Mar 30).","journal-title":"J Biol Chem"},{"issue":"9","key":"1334_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMra2104091","volume":"385","author":"JH Levy","year":"2021","unstructured":"Levy JH, Connors JM. Heparin resistance: clinical perspectives and management strategies. N Engl J Med. 2021;385(9):826\u201332. https:\/\/doi.org\/10.1056\/NEJMra2104091.","journal-title":"N Engl J Med"},{"issue":"4","key":"1334_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0049-3848(91)90650-l","volume":"61","author":"R Giuliani","year":"1991","unstructured":"Giuliani R, Szwarcer E, Martinez Aquino E, Palumbo G. Fibrin-dependent fibrinolytic activity during extracorporeal circulation. Thromb Res. 1991;61(4):369\u201373. https:\/\/doi.org\/10.1016\/0049-3848(91)90650-l.","journal-title":"Thromb Res"},{"issue":"4 Suppl. 1","key":"1334_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1053-0770(21)00594-2","volume":"13","author":"GJ Despotis","year":"1999","unstructured":"Despotis GJ, Joist JH. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. J Cardiothorac Vasc Anesth. 1999;13(4 Suppl. 1):18\u201329 (discussion 36\u20137).","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1051\/ject\/1980126139","volume":"12","author":"EJ Cohen","year":"1980","unstructured":"Cohen EJ. J Extra Corpor Technol. 1980;12:139.","journal-title":"J Extra Corpor Technol"},{"issue":"6","key":"1334_CR32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/biomedicines9060700","volume":"9","author":"J Amiral","year":"2021","unstructured":"Amiral J, Amiral C, Dunois C. Optimization of heparin monitoring with anti-FXa assays and the impact of dextran sulfate for measuring all drug activity. Biomedicines. 2021;9(6):700. https:\/\/doi.org\/10.3390\/biomedicines9060700.","journal-title":"Biomedicines."},{"issue":"3","key":"1334_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1051\/ject\/201244145","volume":"44","author":"K Palmer","year":"2012","unstructured":"Palmer K, Ridgway T, Al-Rawi O, Poullis M. Heparin therapy during extracorporeal circulation: deriving an optimal activated clotting time during cardiopulmonary bypass for isolated coronary artery bypass grafting. J Extra Corpor Technol. 2012;44(3):145\u201350.","journal-title":"J Extra Corpor Technol"},{"key":"1334_CR34","doi-asserted-by":"publisher","unstructured":"Authors\/Task Force Members; Kunst G, Milojevic M, Boer C, De Somer FMJJ, Gudbjartsson T, van den Goor J, et al.; EACTS\/EACTA\/EBCP Committee Reviewers; Alston P, Fitzgerald D, Nikolic A, Onorati F, Rasmussen BS, Svenmarker S. 2019 EACTS\/EACTA\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019;123(6):713\u201357. https:\/\/doi.org\/10.1016\/j.bja.2019.09.012(Epub 2019 Oct 2).","DOI":"10.1016\/j.bja.2019.09.012"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-023-01334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T11:05:31Z","timestamp":1707217531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-023-01334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s40262-023-01334-3","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"7 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Audrick Gibert, Julien Lanoisel\u00e9e, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex<sup>2<\/sup>, J\u00e9rome Morel, Laurent Gergel\u00e9, Sophie Hodin, Val\u00e9rie Bin, Robin Chaux, Xavier Delavenne, and Edouard Ollier have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conception and design of the study: EO, JL, XD. Data collection: AG, JL, IG-T, AP, KA, AP, NG, SM, JM, LG, SH, VB, XD, EO. Data entry\/inspection\/management: AG, JL, EO. Data analysis: AG, EO. Data interpretation: all authors. Drafting the article: AG, JL, EO. Critical revision of the article: AG, JL, IG-T, XD, EO. Final approval of paper: all authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}